{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:27:42Z","timestamp":1794317262516,"version":"4.9.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"42","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,10]]},"DOI":"10.1093\/eurheartj\/ehag550","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:04:37Z","timestamp":1784639077000},"page":"6349-6351","source":"Crossref","is-referenced-by-count":0,"title":["Weekly Journal Scan: Genetic insights into glucagon-like peptide 1 receptor agonist response, toward precision obesity therapy"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4218-3066","authenticated-orcid":false,"given":"Daniela","family":"Pedicino","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli\u2014IRCCS , Largo A. Gemelli 8, Rome 00168 ,","place":["Italy"]},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine , Largo F. Vito 1, Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-0907","authenticated-orcid":false,"given":"Giovanna","family":"Liuzzo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli\u2014IRCCS , Largo A. Gemelli 8, Rome 00168 ,","place":["Italy"]},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine , Largo F. Vito 1, Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2026111008071205000_ehag550-B1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41586-026-10330-z","article-title":"Genetic predictors of GLP1 receptor agonist weight loss and side effects","volume":"653","author":"Su","year":"2026","journal-title":"Nature"},{"key":"2026111008071205000_ehag550-B2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/dom.14988","article-title":"Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: an update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide\/GLP-1 receptor co-agonist tirzepatide","volume":"25","author":"Nauck","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026111008071205000_ehag550-B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103464","article-title":"Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis","volume":"88","author":"Chu","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026111008071205000_ehag550-B6","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B7","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41591-025-04102-x","article-title":"Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice","volume":"32","author":"Kr\u00fcger","year":"2026","journal-title":"Nat Med"},{"key":"2026111008071205000_ehag550-B11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"2026111008071205000_ehag550-B12","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"key":"2026111008071205000_ehag550-B13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41467-018-03910-9","article-title":"Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study","volume":"9","author":"DeBoever","year":"2018","journal-title":"Nat Commun"},{"key":"2026111008071205000_ehag550-B14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00228-015-1868-1","article-title":"Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study","volume":"71","author":"Jensterle","year":"2015","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/42\/6349\/69686411\/ehag550.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/42\/6349\/69686411\/ehag550.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:07:20Z","timestamp":1794316040000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/42\/6349\/8739124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":14,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,11,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag550","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,7]]},"published":{"date-parts":[[2026,7,21]]}}}